Ivosidenib is a targeted therapy for IDH1 gene mutations, primarily used to treat relapsed or refractory acute myeloid leukemia (AML) and cholangiocarcinoma. Domestic prices vary widely, typically ranging from tens of thousands of yuan per box, depending on specifications, region, and medical insurance policies. Please consult your hospital or a reputable pharmacy for specific pricing. Strict adherence to your doctor's instructions is crucial before use; do not purchase or adjust the dosage independently.
Indications and Usage Restrictions
Ivosidenib is indicated for specific patients carrying IDH1 gene mutations. Mutation confirmation through genetic testing is required before use.
It is primarily used as second-line treatment for adult AML patients (relapsed or refractory) and locally advanced or metastatic cholangiocarcinoma.
Price Factors
Specification Differences: Different packaging (e.g., 30 tablets/box) and dosages may cause price fluctuations.
Medical Insurance Policies: Special medical insurance or assistance programs in some regions may reduce out-of-pocket expenses; consult your local medical institution.
Imported vs. Domestic: Currently, the domestic market primarily offers imported original drugs; no generic versions are available. Purchase and Usage Guidelines
Purchase requires a prescription from a qualified hospital or pharmacy; online platforms cannot sell these products indiscriminately.
During treatment, liver function, electrolytes, and cardiac function need to be monitored regularly to prevent drug side effects (such as QT interval prolongation).
Medical Treatment and Medication Recommendations
Patients should have their treatment plan evaluated by an oncology specialist, taking into account pathology reports and genetic testing results to determine its suitability.
If financial constraints are significant, patients can consult hospital social work departments or non-profit organizations for drug assistance programs.
Due to the high price of targeted drugs and significant individual differences in efficacy, it is recommended to obtain detailed information through formal medical channels and strictly adhere to treatment guidelines.
